26 research outputs found
Macrophage TNF-α mediates parathion-induced airway hyperreactivity in guinea pigs.
Organophosphorus pesticides (OPs) are implicated in human asthma. We previously demonstrated that, at concentrations that do not inhibit acetylcholinesterase activity, the OP parathion causes airway hyperreactivity in guinea pigs as a result of functional loss of inhibitory M2 muscarinic receptors on parasympathetic nerves. Because macrophages are associated with asthma, we investigated whether macrophages mediate parathion-induced M2 receptor dysfunction and airway hyperreactivity. Airway physiology was measured in guinea pigs 24 h after a subcutaneous injection of parathion. Pretreatment with liposome-encapsulated clodronate induced alveolar macrophage apoptosis and prevented parathion-induced airway hyperreactivity in response to electrical stimulation of the vagus nerves. As determined by qPCR, TNF-α and IL-1β mRNA levels were increased in alveolar macrophages isolated from parathion-treated guinea pigs. Parathion treatment of alveolar macrophages ex vivo did not significantly increase IL-1β and TNF-α mRNA but did significantly increase TNF-α protein release. Consistent with these data, pretreatment with the TNF-α inhibitor etanercept but not the IL-1β receptor inhibitor anakinra prevented parathion-induced airway hyperreactivity and protected M2 receptor function. These data suggest a novel mechanism of OP-induced airway hyperreactivity in which low-level parathion activates macrophages to release TNF-α-causing M2 receptor dysfunction and airway hyperreactivity. These observations have important implications regarding therapeutic approaches for treating respiratory disease associated with OP exposures
Recommended from our members
Effects Of Autism-Relevant Cytokines And Chemokines On Neurite Outgrowth And Toxicity In The Human LUHMES Neuronal Cell Line.
Recommended from our members
Morphometric Analysis of Axons and Dendrites as a Tool for Assessing Neurotoxicity
Chemical perturbation of the temporal or spatial aspects of axonal or dendritic growth is associated with neurobehavioral deficits in animal models, and structural changes in axons and dendrites are thought to contribute to clinical symptoms associated with diverse neurologic diseases. Consequently, axonal and dendritic morphology are often quantified as functionally relevant endpoints of neurotoxicity. Here, we discuss methods for visualizing and quantifying axonal and dendritic morphology of neurons from the peripheral or central nervous systems in in vitro and ex vivo preparations. These methods include visualization of neuronal cytoarchitecture by immunostaining axon- or dendrite-selective antigens, transfecting cells with cDNA encoding fluorescent proteins, or labeling cells using membrane permeable small molecules that distribute throughout the cytoplasm, Golgi staining or Diolistics, as well as quantifying axonal and dendritic morphology using semi-automated or fully automated image analysis
Antibody Fragments Humanization: Beginning with the End in Mind
International audienceMolecular engineering has made possible to reformat monoclonal antibodies into smaller antigen-binding structures like scFvs, diabodies, Fabs with new potential in vivo applications because they do not induce Fc-mediated functions. However, most of these molecules are from rodent origin. As a consequence, they are immunogenic and approval for administration to humans requires prior humanization. Today, there is no well-identified strategy to create recombinant humanized antibody V-domains that preserve the antigen-binding characteristics of the parental antibody associated with high stability and solubility. Here, we propose a strategy that consists in grafting CDRs onto properly chosen human antibody frameworks in order to reduce immunogenicity. A flowchart indicates the way to proceed in order to introduce an internal affinity purification tag while structural refinements are proposed to maintain antigen-binding characteristics. The best humanized candidates are identified through selection steps including in silico analysis, research scale production followed by early functional evaluation, purification assays, aggregation, and stability assessment